what does marksans pharma do

Marksans Pharma Limited is an Indian pharmaceutical company engaged in the formulation of pharmaceutical products, with a focus on research, development, and manufacturing of finished dosage forms for both domestic and global markets.

what is the future of marksans pharma

The future of Marksans Pharma depends on its ability to innovate in R&D, expand its global footprint, and adapt to evolving healthcare demands, though specific predictions require up-to-date financial analysis.

what is the future of marksans pharma share

The future of Marksans Pharma's share is influenced by market performance, company growth, and industry trends, with current metrics like a PE ratio of 32.9 suggesting investor sentiment but not guaranteed outcomes.

what are the products of marksans pharma

Marksans Pharma offers a range of pharmaceutical formulations, including custom research and development services for global clients, though specific product details are not provided in the context.

what is marksans pharma

Marksans Pharma Limited is an Indian pharmaceutical company established in 2000, specializing in the formulation and development of pharmaceutical products with a global presence and strong R&D capabilities.

Marksans Pharma Limited (MARKSANS) Share Price Today — ₹247

Marksans Pharma Limited (MARKSANS) live stock price is ₹247. Listed on BSE. Sector: Healthcare. Industry: Pharmaceuticals & Biotechnology.

View Marksans Pharma Limited stock charts, financial results, quarterly earnings, shareholding pattern, corporate actions, peer comparison and more on Black Bear Labs.

Compare with other stocks in the Healthcare sector.

Use our Stock CAGR Calculator to calculate returns for Marksans Pharma Limited. Screen stocks with our Stock Screener.

Learn about key metrics: P/E Ratio, Market Cap, ROE, EPS.

MARKSANS

BSE

Marksans Pharma Limited

Healthcare· Pharmaceuticals & Biotechnology· INE750C01026· Scrip: 524404

EN हिन्दी ગુજરાતી मराठी

₹247.00

▲ 5.60 (+0.00%)

2026-06-10

BSE

₹247.00

▲ 5.60

+0.00%

231 trading days · 1Y period

TODAY (BSE)

Open254.30

High255.50

Low245.40

Prev Close252.60

Volume2.14L

Value₹5.4Cr

L: 245.40H: 255.50

Info

Face Value₹1

Listed2002-01-21

ISININE750C01026

SeriesA

BSE Scrip524404

Key Metrics

1D

—

1W

—

1M

—

3M

—

6M

—

Valuation

P/E (TTM)—

P/E (Qtr Ann.)—

P/Sales—

Mkt Cap—

Growth (QoQ)

Revenue+6.22%

PAT+7.47%

EPS+8.45%

Profitability

EBITDA Margin30.0%

Net Margin15.4%

TTM EBITDA M.26.9%

TTM Net M.14.6%

Dividend

Yield—

Latest DPS₹0.8

Payout Ratio34.6%

Growth+33.33%

TTM Revenue

₹2138 Cr

TTM EBITDA

₹576 Cr

TTM PAT

₹312 Cr

TTM EPS

₹6.88

Rev/Share

₹47.2

Quarterly Financials

Revenue

EBITDA

PAT

EPS

Quarter	Revenue	Expenses	EBITDA	PBT	PAT	EPS
2024-12-31	682 Cr	566 Cr	205 Cr	143 Cr	105 Cr	₹2.31
2024-09-30	642 Cr	528 Cr	174 Cr	125 Cr	98 Cr	₹2.13
2024-06-30	255 Cr	220 Cr	49 Cr	42 Cr	32 Cr	₹0.71
2024-03-31	560 Cr	476 Cr	149 Cr	100 Cr	78 Cr	₹1.73
2023-12-31	586 Cr	478 Cr	168 Cr	113 Cr	83 Cr	₹1.84
2023-09-30	531 Cr	436 Cr	163 Cr	114 Cr	84 Cr	₹1.84
2023-03-31	486 Cr	393 Cr	142 Cr	104 Cr	83 Cr	₹1.97
2022-12-31	480 Cr	418 Cr	111 Cr	79 Cr	62 Cr	₹1.56

Shareholding Pattern

CURRENT — 2026-03-31

Promoter43.9%

FII16.8%

DII6.6%

Public56.1%

PROMOTER HOLDING TREND

Corporate Actions

Ex-Date	Type	Purpose
2025-08-01	Dividend	Dividend - Re 0.80 Per Share
2024-09-17	Dividend	Dividend - Rs 0.60 Per Share
2023-06-07	Dividend	Dividend - Re 0.50 Per Share
2022-08-19	Dividend	Annual General Meeting/Dividend - Rs 0.25 Per Share
2021-09-15	Dividend	Annual General Meeting/Dividend - Rs 0.25 Per Share
2021-07-01	Other	Extra-Ordinary General Meeting
2020-09-22	Dividend	Annual General Meeting/Dividend - Rs 0.10 Per Share
2019-09-19	Dividend	Annual General Meeting/Dividend - Rs 0.05 Per Share
2018-09-19	Dividend	Annual General Meeting/Dividend Re 0.05 Per Share
2017-09-19	Dividend	Annual General Meeting/Dividend - Re 0.05 Per Share
2016-09-22	Dividend	Annual General Meeting/Dividend - Re 0.12 Per Share
2015-09-23	Dividend	Annual General Meeting/ Dividend - Re 0.12/- Per Share
2014-09-18	Dividend	Annual General Meeting / Dividend - Re 0.10/- Per Share
2013-09-19	Other	Annual General Meeting
2012-09-20	Other	Annual General Meeting
2011-09-22	Other	Annual General Meeting
2010-09-22	Other	Annual General Meeting
2009-09-17	Other	Annual General Meeting
2008-09-23	Other	Annual General Meeting
2008-03-11	Split	Fv Split Rs.10/- To Re.1/

Earnings Transcripts

Marksans Pharma Limited has informed the Exchange about Transcript of Investors/Analyst meet on Q4 F...

3 Jun 2026NSE40K chars

Read →

Marksans Pharma Limited has informed the Exchange about Audio Recording of investor(s) / analyst(s) ...

27 May 2026NSE1K chars

Read →

Marksans Pharma Limited has informed the Exchange about Investor Presentation

26 May 2026NSE45K chars

Read →

Marksans Pharma Limited has informed the Exchange about Schedule of conference call for analysts and...

19 May 2026NSE3K chars

Read →

Marksans Pharma Limited has informed the Exchange about Investor Presentation

13 Nov 2025NSE40K chars

Read →

Marksans Pharma Limited has informed the Exchange about Schedule of a conference call for analysts ...

31 Oct 2025NSE2K chars

Read →

Price History

Date	Open	High	Low	Close	Volume
2026-06-10	253.70	255.50	245.55	246.92	24.44L
2026-06-03	241.60	248.10	241.19	242.37	27.09L
2026-05-27	251.39	264.40	247.01	249.27	1.48Cr
2026-05-26	221.40	258.80	218.00	254.79	3.81Cr
2026-05-25	214.00	221.35	213.97	220.26	18.13L
2026-05-22	216.00	218.02	210.02	211.86	13.62L
2026-05-21	219.98	221.27	214.37	216.17	10.17L
2026-05-20	215.95	223.76	212.11	217.42	20.27L
2026-05-19	219.95	225.49	215.59	217.30	29.88L
2026-05-18	209.56	219.30	208.10	217.62	63.63L
2026-05-15	203.25	213.45	200.05	207.45	38.69L
2026-05-14	201.05	206.00	197.41	201.92	14.23L
2026-05-13	200.00	203.00	197.02	200.13	10.60L
2026-05-12	203.90	207.26	197.40	198.40	19.58L
2026-05-11	198.81	208.65	193.75	203.28	31.95L
2026-05-08	204.00	205.90	197.22	197.76	15.64L
2026-05-07	197.74	204.00	197.70	203.02	26.79L
2026-05-06	188.90	207.00	188.30	196.20	88.32L
2026-05-05	190.00	190.60	185.00	186.92	6.40L
2026-05-04	187.55	193.33	186.35	189.29	10.69L
2026-04-30	187.00	187.88	181.00	184.63	6.10L
2026-04-29	185.70	191.10	185.00	187.76	8.38L
2026-04-28	191.99	193.06	183.11	184.10	10.98L
2026-04-27	191.00	195.00	190.24	192.12	8.15L
2026-04-24	195.00	195.00	187.00	190.21	14.79L
2026-04-23	178.00	195.68	177.67	193.25	43.79L
2026-04-22	176.20	180.11	175.85	179.56	5.75L
2026-04-21	177.09	178.90	175.53	176.77	6.88L
2026-04-20	179.23	179.23	175.21	176.90	5.50L
2026-04-17	181.90	181.90	178.30	179.23	6.06L

Frequently Asked Questions

About

Marksans Pharma Limited is an Indian pharmaceutical company with a global presence, specializing in the research, manufacturing, and marketing of finished dosage forms. Key products include formulations for cardiovascular, central nervous system, and metabolic disorders. Notably, the company has a market capitalization of approximately ₹72.6 billion as of recent data.